ICS distribution center will serve manufacturers of specialty medications, biosimilars, and cell and gene therapies.
ICS, a part of AmerisourceBergen, announced on Aug. 29, 2018 the opening of a third-party logistics pharmaceutical distribution center in Lockbourne, OH, which will serve as the flagship location. The largest facility in the company’s network, the 350,000-sq.-ft. distribution center will feature operations tools and technology and a logistics system to accommodate products of different sizes, temperatures, and storage needs. The facility is a certified Foreign Trade Zone Solution, which allows manufacturers to store products awaiting FDA approval in a duty-free environment.
The emergence of high-value products such as cell and gene therapies has increased the demand for rigorous and customized storage solutions, ICS reported in a press statement. The distribution center will enable the company to meet the needs for time-sensitive and ultra-frozen capabilities.
With the addition of the new facility in Ohio, ICS reports it has more than 925,000-sq.-ft .of managed warehouse at four locations within the United States.
Source: ICS, AmerisourceBergen
Thermo Fisher Opens Advanced Therapies Collaboration Center in California
April 18th 2025The 6000-square-foot facility will provide cell therapy developers the support they need to transition to CGMP manufacturing, and an expanded footprint of the new center is expected to open in Philadelphia later in 2025.